Kenichiro Ito

2.0k total citations
65 papers, 1.6k citations indexed

About

Kenichiro Ito is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kenichiro Ito has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kenichiro Ito's work include Advanced biosensing and bioanalysis techniques (9 papers), RNA Interference and Gene Delivery (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Kenichiro Ito is often cited by papers focused on Advanced biosensing and bioanalysis techniques (9 papers), RNA Interference and Gene Delivery (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Kenichiro Ito collaborates with scholars based in Japan, United States and Armenia. Kenichiro Ito's co-authors include Makoto Komiyama, Yan Xu, Koji Kimata, S Suzuki, Yuta Suzuki, Hiroaki Suga, Ian M. Adcock, Mitsuko Sobue, Toby Passioura and Sakaru Suzuki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Kenichiro Ito

65 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenichiro Ito Japan 24 897 285 217 193 138 65 1.6k
Juhani Saarinen Finland 25 1.1k 1.2× 319 1.1× 271 1.2× 96 0.5× 109 0.8× 37 2.4k
Yohko U. Katagiri Japan 21 903 1.0× 227 0.8× 232 1.1× 88 0.5× 380 2.8× 53 1.8k
Norihito Kawasaki Japan 27 846 0.9× 151 0.5× 280 1.3× 353 1.8× 93 0.7× 60 1.8k
Chiara Urbinati Italy 29 1.3k 1.5× 589 2.1× 172 0.8× 114 0.6× 36 0.3× 55 2.1k
Gerhard Unteregger Germany 16 723 0.8× 91 0.3× 190 0.9× 227 1.2× 32 0.2× 57 1.3k
Daniel Wicklein Germany 24 766 0.9× 122 0.4× 521 2.4× 193 1.0× 60 0.4× 60 1.6k
Dan Duksin Israel 19 888 1.0× 242 0.8× 136 0.6× 47 0.2× 101 0.7× 38 1.5k
Jürgen Langner Germany 27 900 1.0× 280 1.0× 792 3.6× 78 0.4× 133 1.0× 64 2.0k
Lars Uhlin‐Hansen Norway 27 1.1k 1.3× 470 1.6× 688 3.2× 130 0.7× 47 0.3× 56 2.5k
Jenny Wu United States 11 1.1k 1.2× 161 0.6× 693 3.2× 171 0.9× 27 0.2× 14 2.3k

Countries citing papers authored by Kenichiro Ito

Since Specialization
Citations

This map shows the geographic impact of Kenichiro Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichiro Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichiro Ito more than expected).

Fields of papers citing papers by Kenichiro Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenichiro Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichiro Ito. The network helps show where Kenichiro Ito may publish in the future.

Co-authorship network of co-authors of Kenichiro Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Kenichiro Ito. A scholar is included among the top collaborators of Kenichiro Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenichiro Ito. Kenichiro Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asahina, Hajime, Hisashi Tanaka, Ryoichi Honda, et al.. (2023). Real‐world data on the efficacy and safety of immune‐checkpoint inhibitors in elderly patients with non‐small cell lung cancer. Cancer Medicine. 12(10). 11525–11541. 17 indexed citations
2.
Ito, Kenichiro, et al.. (2022). Single-chain tandem macrocyclic peptides as a scaffold for growth factor and cytokine mimetics. Communications Biology. 5(1). 56–56. 8 indexed citations
3.
Asahina, Hajime, Hisashi Tanaka, Ryoichi Honda, et al.. (2021). Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902). Lung Cancer. 156. 12–19. 8 indexed citations
4.
Fukumoto, Shinichi, Satoshi Oizumi, Masao Harada, et al.. (2020). A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703). Cancer Chemotherapy and Pharmacology. 86(1). 117–127. 3 indexed citations
5.
Sakai, Katsuya, Toby Passioura, Hiroki Sato, et al.. (2019). Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor. Nature Chemical Biology. 15(6). 598–606. 58 indexed citations
6.
Hwang, Do Won, Kenichiro Ito, Seunggyun Ha, et al.. (2016). In vivo targeting of c-Met using a non-standard macrocyclic peptide in gastric carcinoma. Cancer Letters. 385. 144–149. 12 indexed citations
7.
Ito, Kenichiro, Katsuya Sakai, Yoshinori Suzuki, et al.. (2015). Artificial human Met agonists based on macrocycle scaffolds. Nature Communications. 6(1). 6373–6373. 90 indexed citations
8.
Muramatsu, Ken, et al.. (2014). Cutaneous Manifestations of Thymoma-associated Multi-organ Autoimmunity: A Fatal Sign. Acta Dermato Venereologica. 96(6). 0–0. 10 indexed citations
9.
Ito, Kenichiro, et al.. (2013). An artificial restriction DNA cutter for site-selective gene insertion in human cells. Chemical Communications. 49(60). 6764–6764. 4 indexed citations
10.
Terui, Keita, et al.. (2013). Pleuroperitoneal Shunt for Refractory Chylothorax Accompanied with a Mediastinal Lymphangioma: A Case Report. Annals of Thoracic and Cardiovascular Surgery. 20(Supplement). 654–658. 2 indexed citations
11.
Ito, Kenichiro & Makoto Komiyama. (2013). Site-Selective Scission of Human Genome Using PNA-Based Artificial Restriction DNA Cutter. Methods in molecular biology. 1050. 111–120. 9 indexed citations
12.
Takahashi, Tadanobu, et al.. (2012). Sulfatide negatively regulates the fusion process of human parainfluenza virus type 3. The Journal of Biochemistry. 152(4). 373–380. 9 indexed citations
13.
Ito, Kenichiro, et al.. (2011). Binding of natural cytotoxicity receptor NKp46 to sulfate- and α2,3-NeuAc-containing glycans and its mutagenesis. Biochemical and Biophysical Research Communications. 406(3). 377–382. 16 indexed citations
14.
Xu, Yan, Yuta Suzuki, Kenichiro Ito, & Makoto Komiyama. (2010). Telomeric repeat-containing RNA structure in living cells. Proceedings of the National Academy of Sciences. 107(33). 14579–14584. 154 indexed citations
15.
Ito, Kenichiro, et al.. (2009). Site-selective scission of human genome by artificial restriction DNA cutter. Chemical Communications. 6542–6542. 25 indexed citations
16.
17.
Ito, Kenichiro, Toshiaki Sato, & Makoto Arita. (2001). Protein kinase C isoform‐dependent modulation of ATP‐sensitive K+ channels during reoxygenation in guinea‐pig ventricular myocytes. The Journal of Physiology. 532(1). 165–174. 15 indexed citations
18.
Takeuchi, F, Ken Nakano, K Matsuta, et al.. (1997). Polymorphism of TAP1 and TAP2 in Japanese patients with rheumatoid arthritis. Tissue Antigens. 49(3). 280–282. 13 indexed citations
19.
Hara, Masahide, Kenichiro Ito, Tomoko Nawata, et al.. (1994). Silent Cerebral Infarction Associated with Coronary Artery Disease. Cardiology. 85(3-4). 171–174. 11 indexed citations
20.
Sobue, Mitsuko, Hiroko Habuchi, Kenichiro Ito, et al.. (1987). β-d-xylosides and their analogues as artificial initiators of glycosaminoglycan chain synthesis. Aglycone-related variation in their effectiveness in vitro and in ovo. Biochemical Journal. 241(2). 591–601. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juhani Saarinen Breakdown of academic impact, for papers by Yohko U. Katagiri Breakdown of academic impact, for papers by Norihito Kawasaki Breakdown of academic impact, for papers by Chiara Urbinati Breakdown of academic impact, for papers by Gerhard Unteregger Breakdown of academic impact, for papers by Daniel Wicklein Breakdown of academic impact, for papers by Dan Duksin Breakdown of academic impact, for papers by Jürgen Langner Breakdown of academic impact, for papers by Lars Uhlin‐Hansen Breakdown of academic impact, for papers by Jenny Wu
Rankless by CCL
2026